Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Whitten

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Design, synthesis, and SAR of 2-dialkylamino-4-arylpyrimidines as potent and selective corticotropin-releasing factor(1) (CRF(1)) receptor antagonistsCharles Q Huang, Dimitri E Grigoriadis, Zhengyu Liu, et al.
Journal of Medicinal Chemistry|July 1, 1990
1-(Thienylalkyl)imidazole-2(3H)-thiones as potent competitive inhibitors of dopamine beta-hydroxylaseJ R McCarthy, D P Matthews, R J Broersma, et al.
Journal of Medicinal Chemistry|January 1, 1990
Synthesis and cardiotonic activity of novel biimidazolesD P Matthews, J R McCarthy, J P Whitten, et al.
Journal of Medicinal Chemistry|September 1, 1985
6,7-Dihydro-5-[[(cis-2-hydroxy-trans-3-phenoxycyclopentyl)amino] methyl]-2-methylbenzo[b]thiophen-4(5H)-one: a novel alpha 1-adrenergic receptor antagonist and renal vasodilatorJ R McCarthy, M B Zimmerman, D L Trepanier, et al.
Applied Occupational and Environmental Hygiene|January 5, 2002
Indoor environmental quality in six commercial office buildings in the midwest United StatesS J Reynolds, D W Black, S S Borin, et al.
Journal of Medicinal Chemistry|October 25, 1996
Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor1 receptor antagonistsC Chen, R Dagnino, E B De Souza, et al.
Cancer Research|September 10, 2009
Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesisDenis Drygin, Adam Siddiqui-Jain, Sean O'Brien, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Conformationally restricted analogues of nicotine and anabasineJ M Vernier, H Holsenback, N D Cosford, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of CX-5461, the First Direct and Selective Inhibitor of RNA Polymerase I, for Cancer TherapeuticsMustapha Haddach, Michael K Schwaebe, Jerome Michaux, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases InhibitorMustapha Haddach, Jerome Michaux, Michael K Schwaebe, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Design, synthesis, and SAR of 2-dialkylamino-4-arylpyrimidines as potent and selective corticotropin-releasing factor(1) (CRF(1)) receptor antagonistsCharles Q Huang, Dimitri E Grigoriadis, Zhengyu Liu, et al.
Journal of Medicinal Chemistry|July 1, 1990
1-(Thienylalkyl)imidazole-2(3H)-thiones as potent competitive inhibitors of dopamine beta-hydroxylaseJ R McCarthy, D P Matthews, R J Broersma, et al.
Journal of Medicinal Chemistry|January 1, 1990
Synthesis and cardiotonic activity of novel biimidazolesD P Matthews, J R McCarthy, J P Whitten, et al.
Journal of Medicinal Chemistry|September 1, 1985
6,7-Dihydro-5-[[(cis-2-hydroxy-trans-3-phenoxycyclopentyl)amino] methyl]-2-methylbenzo[b]thiophen-4(5H)-one: a novel alpha 1-adrenergic receptor antagonist and renal vasodilatorJ R McCarthy, M B Zimmerman, D L Trepanier, et al.
Applied Occupational and Environmental Hygiene|January 5, 2002
Indoor environmental quality in six commercial office buildings in the midwest United StatesS J Reynolds, D W Black, S S Borin, et al.
Journal of Medicinal Chemistry|October 25, 1996
Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor1 receptor antagonistsC Chen, R Dagnino, E B De Souza, et al.
Cancer Research|September 10, 2009
Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesisDenis Drygin, Adam Siddiqui-Jain, Sean O'Brien, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Conformationally restricted analogues of nicotine and anabasineJ M Vernier, H Holsenback, N D Cosford, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of CX-5461, the First Direct and Selective Inhibitor of RNA Polymerase I, for Cancer TherapeuticsMustapha Haddach, Michael K Schwaebe, Jerome Michaux, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases InhibitorMustapha Haddach, Jerome Michaux, Michael K Schwaebe, et al.
Pageof 7